Supraclavicular Brachial Plexus Block as Opioid Sparing Technique in Pediatrics Undergoing Arteriovenous Fistula Creation

NCT07012616 | Completed

• 1 other identifier: 36264PR1208/5/25
• Study Type: interventional
• Target: 50
• Locations: 1 country
• Sites: 1

Brief Summary

This study aims to evaluate the efficacy of supraclavicular brachial plexus block as an opioid-sparing technique in pediatric patients undergoing arteriovenous fistula creation.

Conditions

Supraclavicular Brachial Plexus Block; Opioid Sparing; Pediatric; Arteriovenous Fistula

Outcome Measures

Primary Outcomes (1)

• Intraoperative fentanyl consumption

  Intraoperatively

Secondary Outcomes (5)

• Total opioid consumption

  24 hours postoperatively

• Time to the 1st rescue analgesia

  24 hours postoperatively

• Degree of pain

  24 hours postoperatively

• Patient satisfaction

  24 hours postoperatively

• Incidence of adverse events

  24 hours postoperatively

Study Arms (2)

Supraclavicular brachial plexus block group

EXPERIMENTAL

Patients will receive an ultrasound-guided supraclavicular brachial plexus block.

Other: Supraclavicular brachial plexus block

Control group

NO INTERVENTION

Patients will not receive supraclavicular brachial plexus block as a control group.

Interventions

Supraclavicular brachial plexus block OTHER

Patients will receive an ultrasound-guided supraclavicular brachial plexus block.

Supraclavicular brachial plexus block group

Eligibility Criteria

• Age: 6 Years - 18 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64)

You may qualify if:

• Age from 6 to 18 years.
• Both sexes.
• American Society of Anesthesiology (ASA) physical status I- III.
• Undergoing arteriovenous fistula creation under general anesthesia.

You may not qualify if:

• Allergy to local anesthetics.
• Infection at the site of block.
• Local infection.
• Coagulation disorder.
• Previously failed or revision of blocked arteriovenous fistula.

Sponsors & Collaborators

• Tanta University: lead

Study Sites (1)

Tanta University

Tanta, El-Gharbia, 31527, Egypt

Location

MeSH Terms

Conditions

Arteriovenous Fistula

Condition Hierarchy (Ancestors)

Arteriovenous Malformations; Vascular Malformations; Cardiovascular Abnormalities; Cardiovascular Diseases; Vascular Fistula; Vascular Diseases; Congenital Abnormalities; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Fistula; Pathological Conditions, Anatomical; Pathological Conditions, Signs and Symptoms

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Lecturer of Anesthesiology, Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Tanta University, Tanta, Egypt

Study Record Dates

• First Submitted: May 31, 2025
• First Posted: June 10, 2025
• Study Start: June 10, 2025
• Primary Completion: January 15, 2026
• Study Completion: January 15, 2026
• Last Updated: January 29, 2026

Record last verified: 2026-01

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL
• Time Frame: After the end of study for one year.
• Access Criteria: The data will be available upon a reasonable request from the corresponding author.

Locations

EG (1)